Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$151K Sell
13,872
-655
-5% -$6.99K ﹤0.01% 1049
2026
Q1
$145K Sell
14,527
-1,552
-10% -$19.8K ﹤0.01% 1020
2025
Q4
$264K Buy
+16,079
New +$250K 0.01% 633

Other funds holding PATH

VestGen Advisors's PATH Position: Q2 2026 in Review

VestGen Advisors reduced its UiPath (PATH) stake by 4.5% in Q2 2026, selling an estimated $6.99K and leaving 13,872 shares worth $151K. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

VestGen Advisors first reported a position in PATH in Q4 2025 and has held it in 3 quarters since. The position peaked at $264K in Q4 2025. 526 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • VestGen Advisors held 13,872 shares of UiPath worth $151K as of Q2 2026.
  • VestGen Advisors sold 655 UiPath shares in Q2 2026, an estimated $6.99K.
  • UiPath made up ﹤0.01% of VestGen Advisors's portfolio in Q2 2026, its #1049 holding.
  • VestGen Advisors first reported a position in UiPath in Q4 2025 and has held it in 3 quarters since.
  • VestGen Advisors's UiPath position peaked at $264K in Q4 2025.
  • 526 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.